Full Text View
Tabular View
No Study Results Posted
Related Studies
Akt Inhibitor MK2206 in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
This study is currently recruiting participants.
Verified September 2014 by National Cancer Institute (NCI)
Study NCT01481129   Information provided by National Cancer Institute (NCI)

First Received on November 24, 2011.   Last Updated on November 21, 2014   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Sponsors listed in this trial